Skip to main content
Top
Published in: Clinical Rheumatology 7/2010

01-07-2010 | Original Article

Juvenile idiopathic arthritis among Nigerians: a case study

Authors: Olufemi O. Adelowo, A. Umar

Published in: Clinical Rheumatology | Issue 7/2010

Login to get access

Abstract

Juvenile idiopathic arthritis (JIA) has rarely been reported among Black Africans. This retrospective case study was part of an audit of cases presenting to a private practice rheumatology clinic in Lagos, Nigeria. The objective of this study was to determine the clinical, laboratory, and radiographic features of patients with JIA, as well as to highlight their management. A total of 23 cases (F-16:M-7) were seen over an 8.5-year period. Polyarticular presentation was the commonest while systemic onset was the least. The mean age at presentation was 12.7 years. Most of the patients presented late with mean of 3.7 years before presentation. The knees and ankles were most commonly involved. ESR was elevated in most of the cases. Rheumatoid factor and Antinuclear antibodies were invariably negative. Treatments were with standard drugs. Although JIA is uncommonly seen in our population, the clinical and laboratory features are similar as elsewhere, though there are some differences.
Literature
1.
go back to reference Cassidy JT, Levinson JE, Bass JC et al (1986) A study of classification criteria for a diagnosis of juvenile rheumatoid arthritis. Arthritis Rheum 29:274–287CrossRefPubMed Cassidy JT, Levinson JE, Bass JC et al (1986) A study of classification criteria for a diagnosis of juvenile rheumatoid arthritis. Arthritis Rheum 29:274–287CrossRefPubMed
2.
go back to reference Singsen BH (1990) Rheumatic diseases of childhood. Rheum Dis Clin North Am 16:581–599PubMed Singsen BH (1990) Rheumatic diseases of childhood. Rheum Dis Clin North Am 16:581–599PubMed
3.
go back to reference Petty RE, Southwood TR, Baum J et al (1998) Revision of the proposed classification criteria for juvenile arthritis: Durban 1997. J Rheumatol 25:1991–1994PubMed Petty RE, Southwood TR, Baum J et al (1998) Revision of the proposed classification criteria for juvenile arthritis: Durban 1997. J Rheumatol 25:1991–1994PubMed
4.
go back to reference Gare BA (1994) Juvenile chronic arthritis. A population based study on epidemiology, natural history and outcome. University of Goteborg, Goteborg, Sweden Gare BA (1994) Juvenile chronic arthritis. A population based study on epidemiology, natural history and outcome. University of Goteborg, Goteborg, Sweden
5.
go back to reference Moe N, Rygg M (1998) Epidemiology of juvenile chronic arthritis in northern Norway: a ten-year prospective study. Clin Exp Rheumatol 16:99–101PubMed Moe N, Rygg M (1998) Epidemiology of juvenile chronic arthritis in northern Norway: a ten-year prospective study. Clin Exp Rheumatol 16:99–101PubMed
6.
go back to reference Denardo BA, Tucker LB, Miller LC et al (1994) Demography of a regional pediatric rheumatology patient population. Affiliated children’s arthritis centers of New England. J Rheumatol 21:1553–1561PubMed Denardo BA, Tucker LB, Miller LC et al (1994) Demography of a regional pediatric rheumatology patient population. Affiliated children’s arthritis centers of New England. J Rheumatol 21:1553–1561PubMed
7.
go back to reference Towner SR, Michet CJ, O’Fallon WM et al (1983) The epidemiology of juvenile arthritis in Rochester, Minnesota, 1960–1979. Arthritis Rheum 26:1208–1213CrossRefPubMed Towner SR, Michet CJ, O’Fallon WM et al (1983) The epidemiology of juvenile arthritis in Rochester, Minnesota, 1960–1979. Arthritis Rheum 26:1208–1213CrossRefPubMed
8.
9.
go back to reference Chantler JK et al (1985) Persistent rubella virus infection associated with chronic arthritis in children. N Engl J Med 313:1117–1123PubMedCrossRef Chantler JK et al (1985) Persistent rubella virus infection associated with chronic arthritis in children. N Engl J Med 313:1117–1123PubMedCrossRef
10.
go back to reference Gear AJ, Venables PJW, Edwards JMB, Maini RN, Ansell BM (1986) Rheumatoid arthritis, juvenile arthritis, iridocyclitis and the Epstein–Barr virus. Ann Rheum Dis 45:6–8CrossRefPubMed Gear AJ, Venables PJW, Edwards JMB, Maini RN, Ansell BM (1986) Rheumatoid arthritis, juvenile arthritis, iridocyclitis and the Epstein–Barr virus. Ann Rheum Dis 45:6–8CrossRefPubMed
11.
go back to reference McGill P, Oyoo OO (2002) Rheumatic disorders in Sub-Saharan Africa. East Afr Med J Apr 74(4):214–216 McGill P, Oyoo OO (2002) Rheumatic disorders in Sub-Saharan Africa. East Afr Med J Apr 74(4):214–216
12.
go back to reference Cassidy JT, Petty RE (2001) Juvenile rheumatoid arthritis. In: Cassidy JT, Petty RE (eds) Textbook of pediatric rheumatology, 4th edn. WB Saunders, Philadelphia PA, pp 218–321 Cassidy JT, Petty RE (2001) Juvenile rheumatoid arthritis. In: Cassidy JT, Petty RE (eds) Textbook of pediatric rheumatology, 4th edn. WB Saunders, Philadelphia PA, pp 218–321
13.
go back to reference White PH (1998) Juvenile chronic arthritis. In: Klippel JH, Dieppe PA (eds) Rheumatology, 2nd edn. Mosby, London, pp 18.1–18.10, P (5) White PH (1998) Juvenile chronic arthritis. In: Klippel JH, Dieppe PA (eds) Rheumatology, 2nd edn. Mosby, London, pp 18.1–18.10, P (5)
14.
go back to reference White PH (1990) Growth abnormalities in children with juvenile rheumatoid arthritis. Clin Orthop Rel Res 23:727–729 White PH (1990) Growth abnormalities in children with juvenile rheumatoid arthritis. Clin Orthop Rel Res 23:727–729
15.
go back to reference Simon S, Whitten J, Shapiro F (1981) Leg-length discrepancies in monoarticular and pauciarticular juvenile rheumatoid arthritis. J Bone J Surg 63A:209–215 Simon S, Whitten J, Shapiro F (1981) Leg-length discrepancies in monoarticular and pauciarticular juvenile rheumatoid arthritis. J Bone J Surg 63A:209–215
16.
go back to reference Wu JF, Yang YH, Wang LC, Lee JH, Shen EY, Chiang BL (2007) Comparative usefulness of C reactive protein and erythrocyte sedimentation rate in juvenile rheumatoid arthritis. Clin Exp Rheumatol 25(5):782–785PubMed Wu JF, Yang YH, Wang LC, Lee JH, Shen EY, Chiang BL (2007) Comparative usefulness of C reactive protein and erythrocyte sedimentation rate in juvenile rheumatoid arthritis. Clin Exp Rheumatol 25(5):782–785PubMed
17.
go back to reference Slater CA, Davis RB, Shmerling RH (1996) Antinuclear antibody testing. A study of clinical utility. Arch Intern Med 156(13):1421–1425CrossRefPubMed Slater CA, Davis RB, Shmerling RH (1996) Antinuclear antibody testing. A study of clinical utility. Arch Intern Med 156(13):1421–1425CrossRefPubMed
18.
go back to reference Shmerling RH, Delbanco TL (1992) How useful is the rheumatoid factor? An analysis of sensitivity, specificity and predictive value. Arch Intern Med 152(12):2417–2420CrossRefPubMed Shmerling RH, Delbanco TL (1992) How useful is the rheumatoid factor? An analysis of sensitivity, specificity and predictive value. Arch Intern Med 152(12):2417–2420CrossRefPubMed
19.
go back to reference Haines KA (2007) Juvenile idiopathic arthritis; therapies in the 21st century. Bull NYU Hosp JT Dis 65(3):205–211PubMed Haines KA (2007) Juvenile idiopathic arthritis; therapies in the 21st century. Bull NYU Hosp JT Dis 65(3):205–211PubMed
20.
Metadata
Title
Juvenile idiopathic arthritis among Nigerians: a case study
Authors
Olufemi O. Adelowo
A. Umar
Publication date
01-07-2010
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 7/2010
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-010-1401-y

Other articles of this Issue 7/2010

Clinical Rheumatology 7/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine